custom genome resequencing microarrays (customseq ) (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
custom genome resequencing microarrays (customseq )
Custom Genome Resequencing Microarrays (Customseq ), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/custom+genome+resequencing+microarrays+(customseq+)/pm15846219-26-0-14
Average 90 stars, based on 1 article reviews
Custom Genome Resequencing Microarrays (Customseq ), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/custom+genome+resequencing+microarrays+(customseq+)/pm15846219-26-0-14
Average 90 stars, based on 1 article reviews
custom genome resequencing microarrays (customseq ) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Microarray:Article Title: Screening candidate genes for mutations in patients with hypogonadotropic hypogonadism using custom genome resequencing microarrays. Article Snippet: American Journal of Obstetrics and Gynecology (2005) 192, 1274–84 www.ajog.org Screening candidate genes for mutations in patients with hypogonadotropic hypogonadism using custom genome resequencing microarrays Ning Xu, MB,a,b Robert H. Podolsky, PhD,c Pranav Chudgar, BS,a,b Lynn P. Chorich, MS,a,b Chunmei Liu, MS,d Paul G. McDonough, MD,a Janet A. Warrington, PhD,d Lawrence C. Layman, MDa,b,* Section of Reproductive Endocrinology, Infertility, and Genetics,a Department of Obstetrics and Gynecology, Neurodevelopmental Biology Program,b The Institute of Molecular Medicine and Genetics, Department of Biostatistics and Bioinformatics,c The Medical College of Georgia, Augusta, Ga, and Affymetrix, Inc, Santa Clara, Calif d Received for publication December 2, 2004; revised December 10, 2004; accepted December 10, 2004 KEY WORDS Idiopathic hypogonadotropic hypogonadism Genomic chip Microarray Custom genome resequencing microarray Objective: The purpose of this study was to determine the consistency of calling single nucleotide polymorphisms (SNPs) by custom genome resequencing microarrays compared with capillary DNA sequencing.. Study design: Amplified genomic DNA from 23 patients with hypogonadotropic hypogonadism was hybridized to microarrays containing 30 kilobases of sequence from 6 different candidate genes.. Capillary DNA sequencing was performed in 10 patients. Produced:Article Title: Screening candidate genes for mutations in patients with hypogonadotropic hypogonadism using custom genome resequencing microarrays. Article Snippet: American Journal of Obstetrics and Gynecology (2005) 192, 1274–84 www.ajog.org Screening candidate genes for mutations in patients with hypogonadotropic hypogonadism using custom genome resequencing microarrays Ning Xu, MB,a,b Robert H. Podolsky, PhD,c Pranav Chudgar, BS,a,b Lynn P. Chorich, MS,a,b Chunmei Liu, MS,d Paul G. McDonough, MD,a Janet A. Warrington, PhD,d Lawrence C. Layman, MDa,b,* Section of Reproductive Endocrinology, Infertility, and Genetics,a Department of Obstetrics and Gynecology, Neurodevelopmental Biology Program,b The Institute of Molecular Medicine and Genetics, Department of Biostatistics and Bioinformatics,c The Medical College of Georgia, Augusta, Ga, and Affymetrix, Inc, Santa Clara, Calif d Received for publication December 2, 2004; revised December 10, 2004; accepted December 10, 2004 KEY WORDS Idiopathic hypogonadotropic hypogonadism Genomic chip Microarray Custom genome resequencing microarray Objective: The purpose of this study was to determine the consistency of calling single nucleotide polymorphisms (SNPs) by custom genome resequencing microarrays compared with capillary DNA sequencing.. Study design: Amplified genomic DNA from 23 patients with hypogonadotropic hypogonadism was hybridized to microarrays containing 30 kilobases of sequence from 6 different candidate genes.. Capillary DNA sequencing was performed in 10 patients. Sequencing:Article Title: Screening candidate genes for mutations in patients with hypogonadotropic hypogonadism using custom genome resequencing microarrays. Article Snippet: American Journal of Obstetrics and Gynecology (2005) 192, 1274–84 www.ajog.org Screening candidate genes for mutations in patients with hypogonadotropic hypogonadism using custom genome resequencing microarrays Ning Xu, MB,a,b Robert H. Podolsky, PhD,c Pranav Chudgar, BS,a,b Lynn P. Chorich, MS,a,b Chunmei Liu, MS,d Paul G. McDonough, MD,a Janet A. Warrington, PhD,d Lawrence C. Layman, MDa,b,* Section of Reproductive Endocrinology, Infertility, and Genetics,a Department of Obstetrics and Gynecology, Neurodevelopmental Biology Program,b The Institute of Molecular Medicine and Genetics, Department of Biostatistics and Bioinformatics,c The Medical College of Georgia, Augusta, Ga, and Affymetrix, Inc, Santa Clara, Calif d Received for publication December 2, 2004; revised December 10, 2004; accepted December 10, 2004 KEY WORDS Idiopathic hypogonadotropic hypogonadism Genomic chip Microarray Custom genome resequencing microarray Objective: The purpose of this study was to determine the consistency of calling single nucleotide polymorphisms (SNPs) by custom genome resequencing microarrays compared with capillary DNA sequencing.. Study design: Amplified genomic DNA from 23 patients with hypogonadotropic hypogonadism was hybridized to microarrays containing 30 kilobases of sequence from 6 different candidate genes.. Capillary DNA sequencing was performed in 10 patients. |